Apollo to bid for GlaxoSmithKline's mature drugs, say sources-Reuters

Apollo Global Management (APO.N) is planning to bid for all GlaxoSmithKline's (GSK.L) mature drugs, joining an auction expected to value the business at more than $3 billion, sources tell Reuters.

DealsNorth AmericaUSBriefs